Obesity, metabolic syndrome, and cardiovascular disease

被引:4
|
作者
Aggoun, Yacine [1 ]
机构
[1] Univ Geneva, Childrens Hosp, Dept Paediat, Paediat Cardiol Unit, CH-1211 Geneva 14, Switzerland
关键词
D O I
10.1203/pdr.0b013e31805d8a8c
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Early childhood overweight and obesity have alarmingly increased over the years. Adulthood obesity is a well demonstrated significant independent predictor of cardiovascular risk (CVR) and/or mortality, which predisposes to the major components of metabolic syndrome (MS). Evidence of MS in obese children has been also reported associated with biochemical and inflammatory factors that affect vascular physiologic function. Assessment of vascular function can be measured noninvasively in children allowing early detection of endothelial dysfunction and severe increase of arterial stiffness before clinical manifestations of atherosclerosis. Impairment of endothelial function related to the severity of obesity and to the degree of insulin resistance is considered as a condition that confers a premature atherogenicity status and is linked to adult conventional cardiovascular risk factors. Adipose tissue factors that interfere with insulin action and endothelial cell function have also been identified as major precursors of CVR factors. The metabolic and cardiovascular consequences of childhood obesity are well demonstrated and have a major impact on the development of atherosclerosis and lifetime CVR. The development of programs involving both diet and exercise for children with overt overweight/obesity appears to be essential to improve vascular function and metabolic disorders. Such interventions should be complemented by a primary prevention against childhood obesity.
引用
收藏
页码:653 / 659
页数:7
相关论文
共 50 条
  • [1] Obesity, the metabolic syndrome, and cardiovascular disease
    Vega, GL
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (06) : 1108 - 1116
  • [2] Obesity, metabolic syndrome, and cardiovascular disease
    Grundy, SM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06): : 2595 - 2600
  • [3] Obesity, Metabolic Syndrome, and Cardiovascular Disease
    Yacine Aggoun
    [J]. Pediatric Research, 2007, 61 : 653 - 659
  • [4] Obesity and metabolic syndrome as related to cardiovascular disease
    Nikolopoulou, Angeliki
    Kadoglou, Nikolaos P. E.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (07) : 933 - 939
  • [5] Leptin: Linking obesity, the metabolic syndrome, and cardiovascular disease
    Patel, Sanjeev B.
    Reams, Garry P.
    Spear, Robert M.
    Freeman, Ronald H.
    Villarreal, Daniel
    [J]. CURRENT HYPERTENSION REPORTS, 2008, 10 (02) : 131 - 137
  • [6] Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome
    Vazzana, N.
    Santilli, F.
    Sestili, S.
    Cuccurullo, C.
    Davi, G.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (34) : 5267 - 5280
  • [7] Leptin: Linking obesity, the metabolic syndrome, and cardiovascular disease
    Sanjeev B. Patel
    Garry P. Reams
    Robert M. Spear
    Ronald H. Freeman
    Daniel Villarreal
    [J]. Current Hypertension Reports, 2008, 10
  • [8] Prevention of cardiovascular disease: Obesity, diabetes and the metabolic syndrome
    Padwal, Raj S.
    Sharma, Arya M.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 18C - 20C
  • [9] A clinical perspective of obesity, metabolic syndrome and cardiovascular disease
    Han, Thang S.
    Lean, Mike E. J.
    [J]. JRSM CARDIOVASCULAR DISEASE, 2016, 5
  • [10] Childhood obesity, hypertension, the metabolic syndrome and adult cardiovascular disease
    Beilin, Lawrence
    Huang, Rae-Chi
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (04): : 409 - 411